-
Something wrong with this record ?
Malignant melanoma in the Czech Republic: incidence and mortality according to sex, age and disease stage
J. Vranova, M. Arenbergerova, P. Arenberger, A. Vrana, J. Zivcak, H. Kolarova, J. Rosina,
Language English Country Czech Republic
Document type Journal Article, Research Support, Non-U.S. Gov't
NLK
Directory of Open Access Journals
from 2001
Free Medical Journals
from 1998
Medline Complete (EBSCOhost)
from 2007-06-01
ROAD: Directory of Open Access Scholarly Resources
from 2001
- MeSH
- Adult MeSH
- Incidence MeSH
- Middle Aged MeSH
- Humans MeSH
- Melanoma mortality pathology MeSH
- Survival Rate MeSH
- Skin Neoplasms mortality pathology MeSH
- Risk Factors MeSH
- Aged, 80 and over MeSH
- Aged MeSH
- Neoplasm Staging MeSH
- Check Tag
- Adult MeSH
- Middle Aged MeSH
- Humans MeSH
- Male MeSH
- Aged, 80 and over MeSH
- Aged MeSH
- Female MeSH
- Publication type
- Journal Article MeSH
- Research Support, Non-U.S. Gov't MeSH
- Geographicals
- Czech Republic MeSH
BACKGROUND: The Czech Republic has reported one of the highest incidence rates of cutaneous melanoma (CM) in Europe and the rate continues to rise. Our study undertook a detailed investigation of the incidence and mortality of melanoma relative to sex, age and disease stage. The main goals were to elucidate the causes of the rising trends and explain the differences in development relative to sex, age and disease stage. METHODS AND RESULTS: The estimated annual percentage change (EAPC) using the Joinpoint Regression Model was calculated separately for men and women for all age categories and for all T stages of TNM classification. The EAPC for women was slightly higher than for men. This was only found in melanomas thinner than 1 mm (T1). For all other stages (T2, T3 and T4) the situation was worse in men. A higher incidence rate of CM and the higher value of EAPC were found for women in younger age categories (up to 49 years). In the next age category, from 50 to 59 years, the incidence of CM was comparable in both sexes as well as the EAPC. In the older age categories, i.e. 60 years and older, a significant increase was found predominantly in men. The mortality rates were only comparable between men and women in the 20 to 29 year age group. In all other categories there was a higher mortality for men. CONCLUSIONS: The number of melanoma cases in the Czech Republic is increasing faster than any other cancer. Despite improved survival rates, the death rate from CM continues to climb as a result of exponential increases in incidence. Thus primary and secondary prevention campaigns are essential for future reductions in CM incidence and mortality in the Czech Republic.
2nd Faculty of Medicine Charles University Prague
Department of Dermatovenerology 3rd Faculty of Medicine Charles University Prague
Faculty of Biomedical Engineering Czech Technical University Prague Kladno
References provided by Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc16031511
- 003
- CZ-PrNML
- 005
- 20161122095903.0
- 007
- ta
- 008
- 161103s2014 xr d f 000 0|ENG||
- 009
- AR
- 024 7_
- $a 10.5507/bp.2012.081 $2 doi
- 035 __
- $a (PubMed)23128825
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a ENG
- 044 __
- $a xr
- 100 1_
- $a Vránová, Jana $u Department of Medical Biophysics and Medical Informatics, 3rd Faculty of Medicine, Charles University, Prague, Czech Republic $7 xx0099427
- 245 10
- $a Malignant melanoma in the Czech Republic: incidence and mortality according to sex, age and disease stage / $c J. Vranova, M. Arenbergerova, P. Arenberger, A. Vrana, J. Zivcak, H. Kolarova, J. Rosina,
- 520 9_
- $a BACKGROUND: The Czech Republic has reported one of the highest incidence rates of cutaneous melanoma (CM) in Europe and the rate continues to rise. Our study undertook a detailed investigation of the incidence and mortality of melanoma relative to sex, age and disease stage. The main goals were to elucidate the causes of the rising trends and explain the differences in development relative to sex, age and disease stage. METHODS AND RESULTS: The estimated annual percentage change (EAPC) using the Joinpoint Regression Model was calculated separately for men and women for all age categories and for all T stages of TNM classification. The EAPC for women was slightly higher than for men. This was only found in melanomas thinner than 1 mm (T1). For all other stages (T2, T3 and T4) the situation was worse in men. A higher incidence rate of CM and the higher value of EAPC were found for women in younger age categories (up to 49 years). In the next age category, from 50 to 59 years, the incidence of CM was comparable in both sexes as well as the EAPC. In the older age categories, i.e. 60 years and older, a significant increase was found predominantly in men. The mortality rates were only comparable between men and women in the 20 to 29 year age group. In all other categories there was a higher mortality for men. CONCLUSIONS: The number of melanoma cases in the Czech Republic is increasing faster than any other cancer. Despite improved survival rates, the death rate from CM continues to climb as a result of exponential increases in incidence. Thus primary and secondary prevention campaigns are essential for future reductions in CM incidence and mortality in the Czech Republic.
- 650 _2
- $a dospělí $7 D000328
- 650 _2
- $a senioři $7 D000368
- 650 _2
- $a senioři nad 80 let $7 D000369
- 650 _2
- $a ženské pohlaví $7 D005260
- 650 _2
- $a lidé $7 D006801
- 650 _2
- $a incidence $7 D015994
- 650 _2
- $a mužské pohlaví $7 D008297
- 650 _2
- $a melanom $x mortalita $x patologie $7 D008545
- 650 _2
- $a lidé středního věku $7 D008875
- 650 _2
- $a staging nádorů $7 D009367
- 650 _2
- $a rizikové faktory $7 D012307
- 650 _2
- $a nádory kůže $x mortalita $x patologie $7 D012878
- 650 _2
- $a míra přežití $7 D015996
- 651 _2
- $a Česká republika $x epidemiologie $7 D018153
- 655 _2
- $a časopisecké články $7 D016428
- 655 _2
- $a práce podpořená grantem $7 D013485
- 700 1_
- $a Arenbergerová, Monika, $d 1971- $7 xx0074761 $u Department of Dermatovenerology, 3rd Faculty of Medicine, Charles University, Prague
- 700 1_
- $a Arenberger, Petr, $d 1958- $7 nlk19990072992 $u Department of Dermatovenerology, 3rd Faculty of Medicine, Charles University, Prague
- 700 1_
- $a Vrána, Antonín $7 xx0314265 $u 2nd Faculty of Medicine, Charles University, Prague
- 700 1_
- $a Živčák, Jozef $7 mzk2005271954 $u Department of Biomedical Engineering, Automation and Measurement, Faculty of Mechanical Engineering, Technical University of Kosice, Slovak Republic
- 700 1_
- $a Kolářová, Hana, $d 1961- $7 _gn020022061 $u Department of Medical Biophysics, Institute of Molecular and Translational Medicine Faculty of Medicine and Dentistry, Palacky University Olomouc
- 700 1_
- $a Rosina, Jozef, $d 1956- $7 nlk19990073785 $u Faculty of Biomedical Engineering, Czech Technical University in Prague, Kladno; Department of Medical Biophysics and Medical Informatics, 3rd Faculty of Medicine, Charles University, Prague, Czech Republic
- 773 0_
- $w MED00012606 $t Biomedical papers of the Medical Faculty of the University Palacky, Olomouc, Czech Republic $x 1213-8118 $g Roč. 158, č. 3 (2014), s. 438-446
- 856 41
- $u http://biomed.papers.upol.cz/ $y domovská stránka časopisu
- 910 __
- $a ABA008 $b A 1502 $c 958 $y 4 $z 0
- 990 __
- $a 20161103 $b ABA008
- 991 __
- $a 20161116100556 $b ABA008
- 999 __
- $a ok $b bmc $g 1173644 $s 956177
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2014 $b 158 $c 3 $d 438-446 $e 20121202 $i 1213-8118 $m Biomedical papers of the Medical Faculty of the University Palacký, Olomouc Czech Republic $n Biomed. Pap. Fac. Med. Palacký Univ. Olomouc Czech Repub. (Print) $x MED00012606
- LZP __
- $b NLK118 $a Pubmed-20161103
